As part of their strategy for endocrine disruptors, the European Commission will take a cross-cutting look at the approach to endocrine disruptors’ assessment and management in a broad range of legislation.
This “Fitness Check” includes two public consultations: a public consultation (designed from a citizen’s perspective) and a stakeholder consultation (designed for stakeholders and experts).
You can have your say! The online survey can be found here and is open for comments until 31 January 2020.
The FREIA consortium met on 29-30 October 2019 to share updates on the work progress. All partners were represented by one or more researchers at the meeting that was hosted by VU Amsterdam.
The first results from the laboratory experiments and computational modelling were presented to the partners. There was some exchange of views on which EDCs should be measured in the human samples that are available within FREIA.
Coordinator Majorie van Duursen: “it was so great to see the enthusiasm and dedication of this wonderful group. We are well on schedule with the planned work”.
Besides the experimental work, the FREIA consortium is working on a review paper to describe how EDCs cause female reproductive health issues. The paper is expected to be published early 2020. Future activities to communicate FREIA goals were also on the agenda. Many great ideas were formed on newsletters and webinars.
All in all, it was a very productive meeting with great promise to achieve FREIA goals.
The European Commission is organising the first annual Forum on Endocrine Disruptors on 8 November at the EC Conference Centre Albert Borschette.
The Forum will bring together scientists, public and private stakeholders with expertise on endocrine disruptors to exchange information and best practices, identify challenges and build synergies, in order to inform the Commission’s reflections.
The programme will include presentations on the latest state of science and human health protection, on national action plans on endocrine disruptors, and on the European Commission’s work on the fitness check to assess whether relevant EU legislation on endocrine disruptors delivers its overall objective to protect human health and the environment.
This Forum is one of the actions in the Commission Communication of November 2018 « Towards a comprehensive European Union Framework on Endocrine Disruptors », outlining a strategic approach to endocrine disruptors for the years to come, with the ultimate goal of ensuring a high level of protection of EU citizens and the environment as well as to preserve an internal market.
There is the possibility to follow the event via webcast or watch the video of the event afterwards. Both services will be made available here.
JUNE 27, 2019 Two months after the European Parliament resolution on the negative impact of a number of chemicals used in food and cosmetics production in the EU, local and regional representatives have called on the European Commission to provide a higher level of protection from hazardous chemicals. According to studies, endocrine disruptors, or EDCs, have a harmful effect on the work of the body’s hormones, leading to infertility, obesity and cancers. In children, they are increasingly linked to autism and other conditions.
JANUARY 28, 2019 | The FREIA project has started with a kick-off meeting in Hotel Zuiderduin (Egmond aan Zee, The Netherlands) on 28 and 29 January 2019. The sister projects ATHENA, ENDpoiNTs, and GOLIATH were having their kick-off meeting at the same venue. The official EU launch was held adjacently in Brussels on 31 January.